Skip to content

Analgesic Effects of Modified Continuous Abdominis Plane Block in Patients undergoing Closure Loop Stoma - A Double-blind Randomized, Controlled Trial.

Analgesic Effects of Modified Continuous Abdominis Plane Block in Patients undergoing Closure Loop Stoma - A Double-blind Randomized, Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151020001
Enrollment
Unknown
Registered
2015-10-20
Start date
2015-10-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with loop stoma undergoing for closue stoma surgery in Chulalongkorn hospital

Interventions

Patients in Modified Continuous Transversus Abdominis group (Modified TAP) will receive 0.2% bupivacaine bolus 5 ml via catheter that lies above posterior sheat in the area of wound intraoperatively.
2ml/hr of 0.2% bupivacaine will continuous dripping over 48 hours. ,Patients in Control group will be placed the catheter as in Modified TAP group but Saline will be used instead.
Experimental Procedure/Surgery,Placebo Comparator Procedure/Surgery
Modified Continuous Transversus Abdominis Plane block ,control

Sponsors

Department of Anesthesiology Chulalongkorn hospital
Lead Sponsor
Department of Colorectal surgery Chulalongkorn hospital
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with loop stroma undergoing for closue stoma surgery in Chulalongkorn hospital 2.Age 18-80 years 3.ASA classification I-III 4.Elective surgery

Exclusion criteria

Exclusion criteria: 1.Patients with history of Chronic pain or history of long term analgesia drug used 2.Pregnancy 3.Intellectual impairment or Psychiatric condition precluding adequate communication 4.Patients with bleeding disorder 5.Patients with infection at inserting catheter area 6.Any problems make Patients cannot use Patient-controlled Analgesic device

Design outcomes

Primary

MeasureTime frame
Total Morphine use 2 days collect from Patients controlled analgesia device

Secondary

MeasureTime frame
Numeric Rating Pain score 2 days visual analog pain scale,Time to first ambulation of the patient 2 days self assessment,Time to first water intake 2 days observation,Time to resumption of clear liquid diet 2 days observation,Time to first flatus 2 days self assessment,Length of hospital stay 2 days Medical record ,complication of catheter insertion or complication from local anesthetic drug 2 days self assessment,Satisfaction of patients 2 days self assessment

Countries

Thailand

Contacts

Public ContactPhantila Cholvisudhi

Anesthesiology Department ,Chulalongkorn hospital

cphantila@gmail.com0896662915

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026